MAPT and Alzheimer disease: Since their discovery, the diagnosis of AD has advanced significantly due to the association with increased levels of both total and phosphorylated Tau protein, alongside a decrease in amyloid peptide levels in the cerebrospinal fluid (CSF) samples [7].